🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesSUSTAIN-6 to SELECT — what worked for you? Page 7

SUSTAIN-6 to SELECT — what worked for you?

fiona_VT Sat, Aug 16, 2025 at 4:04 PM 38 replies 1,492 viewsPage 7 of 8
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Jan 2, 2026 at 10:26 AM#31
Dr.AddMedPHL said:
Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling,…

This answered a question I did not know how to ask. Taking it to my next appointment.

5 3Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 2 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Jan 13, 2026 at 5:24 AM#32

From the other side of the consultation, briefly.

6 month update on cardiovascular risk: down 38 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

Last edited: Jan 13, 2026 at 10:24 AM
6 4CryptoCarl, MariaRD, AussieAnna and 3 others
Reply Quote Save Share Report
ChrisMacros
Member
567
2,345
Sep 2024
Michigan
Jan 24, 2026 at 12:15 AM#33
sophie_paris said:
6 month update on cardiovascular risk: down 38 lbs, off blood pressure meds, A1C normalized.

This matches mine closely enough to be worth saying so out loud.

7 5HPLC_Greg, LibrarianMeg, bri_stats and 4 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Feb 3, 2026 at 7:00 PM#34
sophie_paris said:
6 month update on cardiovascular risk: down 38 lbs, off blood pressure meds, A1C normalized.

There is a second half to this that has not been said yet. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

Last edited: Feb 4, 2026 at 1:00 AM
8 6alex_tucson, kevin_tulsa, Dr.PainCLE and 5 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Feb 14, 2026 at 1:39 PM#35
sophie_paris said:
6 month update on cardiovascular risk: down 38 lbs, off blood pressure meds, A1C normalized.

I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

16 months later: down 63 lbs, off metoprolol, A1C from 8.6% to 5.4%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

9 7tampaLisa73, KarenAZ_mom, zoe_NC and 6 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register